BioSig Technologies, Inc. Common Stock
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of… Read more
BioSig Technologies, Inc. Common Stock (BSGM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.367x
Based on the latest financial reports, BioSig Technologies, Inc. Common Stock (BSGM) has a cash flow conversion efficiency ratio of 0.367x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.28 Million) by net assets ($-3.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioSig Technologies, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how BioSig Technologies, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioSig Technologies, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioSig Technologies, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Austral Resources Australia Ltd
AU:AR1
|
-0.065x |
|
Summer Energy Holdings Inc
OTCQB:SUME
|
0.045x |
|
Newhydrogen Inc
PINK:NEWH
|
-0.181x |
|
Evrofarma SA
AT:EVROF
|
-0.018x |
|
ALT Telecom Public Company Limited
BK:ALT
|
-0.053x |
|
Speciality Restaurants Limited
NSE:SPECIALITY
|
0.095x |
|
HHG Capital Corp
NASDAQ:HHGC
|
-0.002x |
|
Kishin Corporation
KO:092440
|
0.004x |
Annual Cash Flow Conversion Efficiency for BioSig Technologies, Inc. Common Stock (2013–2024)
The table below shows the annual cash flow conversion efficiency of BioSig Technologies, Inc. Common Stock from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.42 Million | $-4.76 Million | 3.346x | -44.20% |
| 2023-12-31 | $-2.89 Million | $-17.31 Million | 5.997x | +110.97% |
| 2022-12-31 | $397.00K | $-21.70 Million | -54.673x | -2502.22% |
| 2021-12-31 | $12.56 Million | $-26.40 Million | -2.101x | -99.64% |
| 2020-12-31 | $25.28 Million | $-26.60 Million | -1.052x | +19.28% |
| 2019-12-31 | $11.88 Million | $-15.48 Million | -1.304x | +51.70% |
| 2018-12-31 | $3.80 Million | $-10.26 Million | -2.699x | -181.84% |
| 2017-12-31 | $-2.26 Million | $-7.47 Million | 3.298x | +10.89% |
| 2016-12-31 | $-1.72 Million | $-5.11 Million | 2.974x | -5.35% |
| 2015-12-31 | $-1.44 Million | $-4.52 Million | 3.142x | +37.21% |
| 2014-12-31 | $-872.06K | $-2.00 Million | 2.290x | +246.34% |
| 2013-12-31 | $-2.67 Million | $-1.76 Million | 0.661x | -- |